Publications by Dr Peter Donaldson - ePrints

Browsing publications by Dr Peter Donaldson.

Newcastle Authors	Title	Year
Dr Peter Donaldson Professor Ann Daly Dr Luca Ermini Professor Debra Bevitt	Genetics of Complex Disease	2015
Dr Rebecca Darlay Dr Kristin Ayers Professor David Jones Dr Peter Donaldson Professor Heather Cordell et al.	Immunochip analysis identifies amino acid residues in five separate HLA genes driving the association between the MHC and primary biliary cirrhosis	2015
Dr Yang-Lin Liu Professor Helen Reeves Professor Alastair Burt Dr Dina Tiniakos Professor Stuart McPherson et al.	TM6SF2 rs58542926 Influences Hepatic Fibrosis Progression in Patients with Non-Alcoholic Fatty Liver Disease	2014
Professor Heather Cordell Dr Peter Donaldson	Baseline Predictive Factors of Ursodeoxycholic Acid Response in Primary Biliary Cirrhosis	2013
Professor Heather Cordell Dr Peter Donaldson	Factors Associated with Poor Outcome in Primary Biliary Cirrhosis	2013
Professor Heather Cordell Samantha Ducker Dr Peter Donaldson Professor David Jones	Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis	2012
Professor Heather Cordell Samantha Ducker Dr Peter Donaldson Professor David Jones	Dense fine-mapping study identifies novel disease loci and implicates coding and non-coding variation in primary Mary cirrhosis risk	2012
Dr Peter Donaldson	Electrostatic modifications of the human leukocyte antigen DR P9 peptide-binding pocket in primary sclerosing cholangitis: Back to the future with human leukocyte antigen DR beta	2011
Professor Heather Cordell Dr Peter Donaldson Samantha Ducker Professor David Jones	Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis	2011
Professor Chris Day Dr Peter Donaldson Professor Ann Daly	Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and class II alleles	2011
Professor Heather Cordell Dr Peter Donaldson Professor David Jones	Genome-wide association study identifies more than 10 primary biliary cirrhosis risk loci	2010
Dr Peter Donaldson Professor Ann Daly Jill Henderson Professor Chris Day	Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury	2010
Professor Heather Cordell Samantha Ducker Dr Peter Donaldson Professor David Jones	Validation of the north american genome-wide association study of primary biliary cirrhosis and identification of additional genetic susceptibility loci in a British cohort	2010
Professor Ann Daly Dr Peter Donaldson Dr Pallav Bhatnagar Julia Patch Professor Heather Cordell et al.	HLA-B5701* genotype is a major determinant of drug-induced liver injury due to flucloxacillin	2009
Dr David Sheridan Dr David Price Dr Matthias Schmid Emeritus Professor Geoffrey Toms Dr Peter Donaldson et al.	Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin	2009
Dr David McDonald Professor Heather Cordell Dr Peter Donaldson Professor Simon Pearce	The tryptophan 620 allele of the lymphoid tyrosine phosphatase (PTPN22 gene) predisposes to autoimmune Addison's disease	2009
Dr Peter Donaldson Dr Pallav Bhatnagar Julia Patch Jill Henderson Julian Leathart et al.	Flucloxacillin-induced liver injury: the extended MHC 57.1 haplotype as a major risk factor	2008
Dr Peter Donaldson Dr Pallav Bhatnagar Julia Patch Jill Henderson Julian Leathart et al.	Susceptibility to drug induced liver injury determined by HLA class II genotype	2008
Dr Peter Donaldson	A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis	2007
Dr Catherine Todhunter Dr Peter Donaldson Dr John Mansfield	Combined Evidence From Three Large British Association Studies Rejects TUCAN/CARD8 as an IBD Susceptibility Gene	2007
Dr Peter Donaldson Professor David Jones Dr John Taylor Emerita Professor Julia Newton Professor Margaret Bassendine et al.	Cytotoxic T-Lymphocyte-Associated Antigen-4 Single Nucleotide Polymorphisms and Haplotypes in Primary Biliary Cirrhosis	2007
Dr Alison Sutherland Jocelyn Davies Dr Kate Owen Professor Timothy Cheetham Dr Robert James et al.	Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility	2007
Dr Peter Donaldson	Immunogenetics of autoimmune liver disease: risk factors for susceptibility and progression	2007
Dr Peter Donaldson	Immunogenetics of Liver Disease	2007
Dr David Price Professor Margaret Bassendine Emeritus Professor Geoffrey Toms Dr Matthias Schmid Dr Christopher Morris et al.	Apolipoprotein ε3 allele is associated with persistent hepatitis C virus infection	2006
Dr Peter Donaldson Dr Anna Baragiotta Professor David Jones Emeritus Professor Oliver James Professor Margaret Bassendine et al.	HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: A large-scale study	2006
Dr David Price Dr Peter Donaldson Julian Leathart Professor Alastair Burt Dr Matthias Schmid et al.	Microsomal triglyceride transfer protein gene promoter polymorphism (493g allele) is associated with severity of hcv-associated steatosis	2006
Dr Peter Donaldson	No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis	2006
Emerita Professor Julia Newton Dr Peter Donaldson Dr Steve Parry Professor Rose Anne Kenny Dr Christopher Morris et al.	Angiotensin converting enzyme insertion/deletion polymorphisms in vasovagal syncope	2005
Dr Peter Donaldson	Basic concepts in primary sclerosing cholangitis: what can we learn from studies of its genetic basis	2005
Dr Catherine Todhunter Maria Price Alison Sutherland-Craggs Dr Peter Donaldson William Cunliffe et al.	CARD 15, smoking, and time to second operation in ileal Crohn's disease	2005
Dr Catherine Todhunter Dr Alison Sutherland Dr Peter Donaldson Professor Ann Daly Emeritus Professor Roger Francis et al.	Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease	2005
Stephen Hartland Emerita Professor Julia Newton Professor Michael Griffin Dr Peter Donaldson	A Functional Polymorphism in the Interleukin-1 Receptor-1 Gene Is Associated with Increased Risk of Helicobacter pylori Infection but Not with Gastric Cancer	2004
Dr David Price Professor Margaret Bassendine Professor Alastair Burt Dr Peter Donaldson	Apolipoprotein E2 protects against persistent hepatitis C virus infection	2004
Dr Anna Baragiotta Dr Kaushik Agarwal Dr Alison Sutherland Professor David Jones Dr Peter Donaldson et al.	Chemokine receptor 5 and primary biliary cirrhosis: A two-centre genetic association study	2004
Dr John Taylor Professor Philip Preshaw Dr Peter Donaldson	Cytokine gene polymorphism and immunoregulation in periodontal disease	2004
Dr Peter Donaldson	Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis	2004
Dr Peter Donaldson	Genetics of autoimmune and viral liver diseases; understanding the issues	2004
Dr Peter Donaldson	Genetics of liver disease: Immunogenetics and disease pathogenesis	2004
Dr Anna Baragiotta Dr Kaushik Agarwal Professor David Jones Dr Peter Donaldson Professor Margaret Bassendine et al.	No evidence for involvement of the CCR5 (chemokine receptor-5) delta 32 mutation in primary biliary cirrhosis	2004
Dr Peter Donaldson	Role of genetics in immunopathogenesis	2004
Dr Valerie Wilson Dr Claire Jennings Dr Kate Owen Dr Peter Donaldson Dr Petros Perros et al.	Role of the CD40 locus in Graves' disease	2004
Dr Valerie Wilson Dr Claire Jennings Dr Kate Owen Susan Herington Dr Peter Donaldson et al.	The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease	2004
Dr Peter Donaldson	A functional polymorphism of the stromelysin gene (MMP3) may influence disease progression in HCV infection	2003
Dr John Taylor Emeritus Professor Oliver James Professor Margaret Bassendine Professor David Jones Dr Peter Donaldson et al.	Caspase 8 gene polymorphism is associated with primary biliary cirrhosis	2003
Dr Peter Donaldson	Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese	2003
Dr John Mansfield Dr Peter Donaldson	Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease	2003
Dr John Mansfield Dr Peter Donaldson	Genetic evidence for interaction of the 5Q31 cytokine locus and the CARD15 gene in Crohn's disease	2003
Professor David Jones Dr Peter Donaldson	Genetic factors in the pathogenesis of primary biliary cirrhosis	2003
Dr Peter Donaldson	Genetics of autoimmune liver disease.	2003
Dr Peter Donaldson	Immunogenetics of Liver Disease	2003
Dr Peter Donaldson	MICA polymorphism and susceptibility to autoimmune hepatitis: Further evidence that susceptibility maps to the HLA class II region on chromosome 6p21.3	2003
Alison Sutherland-Craggs Dr John Mansfield Dr Peter Donaldson Professor Ann Daly Dr Nicholas Thompson et al.	Osteoporosis in Crohn's disease is not determined by vitamin D receptor and interleukin-6 genotype	2003
Emerita Professor Julia Newton Professor Rose Anne Kenny Dr Peter Donaldson	Prevalence of family history in vasovagal syncope and haemodynamic response to head up tilt in first degree relatives: Preliminary data for the Newcastle cohort	2003
Dr Martin Prince Dr Peter Donaldson Dr Mark Hudson	Survival in patients with primary sclerosing cholangitis (PSC). A comparitive study of available prognostic indices	2003
Dr Peter Donaldson	The HLA system and other genetic markers in PSC	2003
Dr Peter Donaldson	A functional polymorphism of the stromelysin gene (MMP3) may influence disease progression in HCV infection	2002
Dr Peter Donaldson	A polymorphism in the interferon gamma gene is not predictive of spontaneous viral clearance or disease progression in HCV infection in a homogenous population of Irish women	2002
Dr Peter Donaldson	Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis	2002
Dr John Taylor Emeritus Professor Oliver James Professor Margaret Bassendine Professor David Jones Dr Peter Donaldson et al.	Caspase 8 gene polymorphism is associated with primary biliary cirrhosis	2002
Dr Peter Donaldson	Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States	2002
Dr Peter Donaldson	Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis	2002
Dr Peter Donaldson	Gender effects and Synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis	2002
Dr Peter Donaldson	Genetic bases of autoimmune hepatitis	2002
Dr Peter Donaldson	Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis	2002
Dr Peter Donaldson	Genetics in autoimmune hepatitis	2002
Dr Peter Donaldson	HLA and cytokine gene polymorphisms in biliary atresia	2002
Dr Peter Donaldson	Immunogenetics of Metabolic Liver Disease	2002
Dr Peter Donaldson	Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy	2002
Dr Peter Donaldson	Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy	2002
Dr Peter Donaldson	MICA polymorphism and susceptibility to hepatitis: Further evidence that susceptibility maps to the HLA class II region on chromosome 6p21.3	2002
Professor Ann Daly Professor Chris Day Dr Peter Donaldson	Polymorphisms in immunoregulatory genes: towards individualised immunosupressive therapy?	2002
Dr Peter Donaldson Professor Chris Day	Predictive Value of Cytokine Polymorphisms for Liver Disease	2002
Dr Peter Donaldson	The immunogenetics of metabolic liver disease	2002
Dr Peter Donaldson	A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis	2001
Dr Ann Curtis Dr Mark Welfare Dr Mark Hudson Dr Peter Donaldson Dr John Mansfield et al.	Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and crohn disease in multiple populations from northeast England	2001
Patrick Harrison Dr Peter Donaldson	Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16-year prospective study	2001
Dr Kaushik Agarwal Dr Peter Donaldson	Gender effects on clinical expression and outcome of type 1 autoimmune hepatitis: Synergisms with known autoimmune promoters	2001
Dr Peter Donaldson Dr Mark Welfare Dr Nicholas Thompson Dr John Mansfield	Genetic association studies in IBD; Negative results from three candidate genes	2001
Dr Peter Donaldson Dr Kaushik Agarwal Emeritus Professor Oliver James Professor David Jones	HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility	2001
Dr Peter Donaldson	HLA class II alleles in Chinese patients with hepatocellular carcinoma	2001
Dr Peter Donaldson	Immunogenetics in PSC	2001
Dr Peter Donaldson	Immunogenetics in PSC	2001
Dr Peter Donaldson	Interleukin-10 gene polymorphisms are not associated with HCV persistence or severity of inflammation in a homogenous population of Irish women.	2001
Dr Roger Vaughan Dr Peter Donaldson	Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: The role of MICA polymorphism	2001
Dr Sharon Cookson Dr Peter Donaldson	MICA alleles do not predispose to chronic rejection following OLT.	2001
Dr Peter Donaldson	Schizophrenia and HLA: A review	2001
Dr Alison Sutherland Dr Mark Welfare Dr Peter Donaldson Dr John Mansfield	The CC chemokine receptor 5 Delta 32 mutation is not associated with inflammatory bowel disease (IBD) in NE England	2001
Dr Peter Donaldson	Transmission disequilibrium analysis of HLA class II DRB1, DQA1, DQB1 and DPB1 polymorphisms in schizophrenia using family trios from a Han Chinese population	2001
Dr Anna Baragiotta Emeritus Professor Oliver James Professor David Jones Joanne Newton Professor Margaret Bassendine et al.	Vitamin D receptor (VDR) TaqI polymorphism in primary biliary cirrhosis (PBC)	2001
Dr Peter Donaldson	A regulatory polymorphism of the stromelysin gene (MMP-3) strongly influences susceptibility to primary sclerosing cholangitis (PSC) and progression to portal hypertension	2000
Joseph O'Donoghue Dr Peter Donaldson	Co-amoxiclav jaundice: clinical, histological features and HLA class II association	2000
Dr Kaushik Agarwal Professor David Jones Dr Peter Donaldson	Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis	2000
Dr Kaushik Agarwal Professor David Jones Dr Peter Donaldson	Cytotoxic T lymphocyte antigen-4 gene polymorphisms and susceptibility to type 1 autoimmune hepatitis	2000
Dr Peter Donaldson	Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis	2000
Dr Peter Donaldson	Genetics of autoimmune liver disease	2000
Dr Peter Donaldson	HLA class II genotypes associated with chronic hepatitis C virus infection and response to α-interferon treatment in Poland	2000
Dr Peter Donaldson	The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: No associations with disease susceptibility/resistance	2000
Dr Peter Donaldson	Association of tumour necrosis factor polymorphism with primary sclerosing cholangitis	1999
Dr Kaushik Agarwal Professor David Jones Dr Peter Donaldson	CTLA-4 gene polymorphism and susceptibility to autoimmune hepatitis	1999
Dr Sharon Cookson Dr Peter Donaldson	Cytokine polymorphisms associated with clinical features and outcome in Type 1 autoimmune hepatitis	1999
Dr Sharon Cookson Dr Peter Donaldson	Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis	1999
Dr Peter Donaldson	Genetics of Autoimmune Liver Disease	1999
Dr Peter Donaldson	Human Leukocyte Antigen-DQB1* genotypes encoding aspartate at position 57 are associated with 3B hydroxysteriod dehydrogenase autoimmunbity in premature ovarian failure	1999
Dr Peter Donaldson	Immunogenetics of Liver Disease	1999
Dr Peter Donaldson Dr Kaushik Agarwal Emeritus Professor Oliver James Professor Margaret Bassendine	Interleukin-1 beta gene polymorphisms are associated with disease progression in primary biliary cirrhosis	1999
Dr Peter Donaldson	Strong association between PSC and HLA-encoded gene MICA008: Is this the primary susceptibility allele?	1999
Dr Peter Donaldson	The interrelationship between hepatitis C virus and HLA	1999
Dr Peter Donaldson	TNF gene polymorphisms in primary biliary cirrhosis: a critical appraisal	1999